Related Experiment Video

Updated: May 14, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

The evolution in melanoma treatment as a reflection of precision-oriented medicine

Igal Kushnir1, Ofer Merimsky

  • 1Department of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel.

Oncology Letters
|February 20, 2013
PubMed

Insights

Melanoma treatment has evolved from dacarbazine chemotherapy to advanced targeted therapies and immunotherapies. This shift reflects a move towards precision medicine, improving patient outcomes in metastatic melanoma.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Metastatic melanoma historically had limited treatment options and a poor prognosis.
  • Dacarbazine was the standard chemotherapy for melanoma, offering limited survival benefits (approx. 7.4 months).
  • Recent molecular understanding has driven the development of novel melanoma therapies.

Purpose of the Study:

  • To review the evolution of melanoma treatment strategies.
  • To highlight the emergence of targeted therapies and immunotherapy.
  • To discuss the impact of precision medicine on melanoma care.

Main Methods:

  • Literature review of melanoma treatment advancements.
  • Analysis of treatment evolution from chemotherapy to targeted agents.
  • Examination of immunotherapy and BRAF inhibitor development.

Main Results:

  • Significant advances in molecular understanding have led to new drugs.
  • Targeted therapies show promise in melanoma and other cancers.
  • Precision medicine allows for tumor-specific treatment approaches.

Conclusions:

  • Melanoma treatment has transformed from single-agent chemotherapy to combination therapies, immunotherapy, and targeted agents.
  • The development of BRAF inhibitors exemplifies targeted therapy success.
  • Treating melanoma based on tumor molecular profiling signifies a paradigm shift in oncology practice.
Keywords:
BRAF inhibitormelanomaprecision medicinetreatment

More Related Videos

A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.